COVID-19 and Posterior Reversible Encephalopathy Syndrome

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an epidemic in December 2019 in Wuhan, China, which became a pandemic (as designated by the WHO), creating a current health emergency.1 A preliminary report warned that SARS-CoV-2 had neuroinvasive potential because some infected patients had neurologic symptoms such as headache, nausea, and vomiting.2 Several subsequent reports have described the emergence of various neurologic disorders in the evolution of SARS-CoV-2 infectious processes. In this article, we report the case of a patient with coronavirus disease 2019 (COVID-19) who presented with posterior reversible encephalopathy syndrome (PRES), diagnosed on clinical, laboratory, and imaging bases.